Clinical Lung Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2023-11-04 ms5000001427749260 来自上海

请问，clinical practice points是啥呀，这个部分应该写什么内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2022-02-28 ms7000000117561646

偏重的研究方向：肿瘤
经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。

79 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2023-07-09 ms8000001615402112 来自浙江省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：肺癌
经验分享：2023.5.4 投稿
2023.6.27 小修
当天修回
2023.7.2 接受
选的是非OA。就1个审稿人。

49 0

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2022-12-03 ms5000000916595472 来自浙江省

前辈们，为什么我attach files那里一直通过不了？我已经都上传啦

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2022-11-10 14699180m53暂无昵称

接受纯数据库的临床预后文章吗

73 0

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2019-11-14 slxbjmu

亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表::
第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表:
第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！

jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！

203 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2019-10-21 jokese

第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！

200 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2022-05-30 钮祜禄

偏重的研究方向：肺癌;肿瘤
经验分享：请问这个杂志接收case report么

70 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2022-09-01 ms5000000599592392

求问版面费多少呀，有人投过传统订阅吗

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147175, encodeId=1169214e1754b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：2023.5.4 投稿 2023.6.27 小修 当天修回 2023.7.2 接受 选的是非OA。就1个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ccf8158297, createdName=ms8000001615402112, createdTime=Sun Jul 09 21:41:37 CST 2023, time=2023-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242373, encodeId=147c12423e3d2, content=求问版面费多少呀，有人投过传统订阅吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b35703719, createdName=ms5000000599592392, createdTime=Thu Sep 01 00:43:50 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236990, encodeId=d3151236990de, content=什么是论著, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936d8164413, createdName=ms8000000798079608, createdTime=Sat Aug 06 21:15:11 CST 2022, time=2022-08-06, status=1, ipAttribution=)]

2022-08-06 ms8000000798079608

什么是论著

61 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务